<DOC>
	<DOCNO>NCT00273039</DOCNO>
	<brief_summary>The purpose study test safety efficacy GW679769 paroxetine subject Social Anxiety Disorder</brief_summary>
	<brief_title>A Study Of A New Medicine ( GW679769 ) For The Treatment Of Social Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Casopitant</mesh_term>
	<criteria>Patients Generalized Social Anxiety Disorder primary diagnosis . If female , must commit consistent correct use acceptable method birth control . Patients psychiatric disorder primary diagnosis within 6 month prior screen . Patients Body Dysmophic Disorder , Schizophrenia , Schizoaffective Disorder , Bipolar Disorder . Patients pose current suicidal homicidal risk make suicide attempt within past 6 month ever homicidal . Patients positive urine test screen illegal drug use and/or history substance abuse dependence ( alcohol drug ) within past 12 month . Patients unstable medical disorder . Female patient pregnant , lactating , plan become pregnant specified time study . Patients take psychoactive medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Social Anxiety Disorder</keyword>
	<keyword>Anxiety</keyword>
	<keyword>Psychiatry</keyword>
</DOC>